Evolus, Inc. (LON:0K16)
London · Delayed Price · Currency is GBP · Price in USD 14.58
+0.43 (3.00%)
At close: Jan 31, 2025
Evolus Market Cap
Evolus has a market cap or net worth of 365.37 million as of August 29, 2025. Its market cap has decreased by -45.87% in one year.
Market Cap
365.37M
Enterprise Value
434.35M
Revenue
202.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.58
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from 194.93M to 365.37M, an increase of 87.44%. That is a compound annual growth rate of 8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 365.37M | -34.57% |
| Dec 31, 2024 | 558.40M | 16.94% |
| Dec 29, 2023 | 477.50M | 36.20% |
| Dec 30, 2022 | 350.58M | 31.20% |
| Dec 31, 2021 | 267.20M | 221.71% |
| Dec 31, 2020 | 83.06M | -72.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 183.76B |
| GSK plc | 58.31B |
| Haleon | 32.51B |
| Smith & Nephew | 12.04B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.95B |
| HUTCHMED (China) | 1.87B |
| Oxford Nanopore Technologies | 1.74B |